NCT06172803

Brief Summary

The overall goal of this study is to find out if rehabilitation exercise can help people who have long COVID. Participants will be randomized by chance to receive either aerobic exercise or breathing exercise (combined with stretches). Participants will be guided and supported in completing a tailored, 6-week home exercise program to be performed 5 - 6 days a week, prescribed and supervised by rehabilitation therapists. Participants will perform breathing exercises, which will be supervised by an occupational therapist. The focus of Aim 1 is to determine feasibility of implementing RESToRE in long COVID.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 14, 2023

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 15, 2023

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2024

Completed
Last Updated

June 6, 2024

Status Verified

June 1, 2024

Enrollment Period

4 months

First QC Date

December 14, 2023

Last Update Submit

June 5, 2024

Conditions

Keywords

RiboflavinRehabiliationLong COVID

Outcome Measures

Primary Outcomes (3)

  • Number of participants who enrolled

    Feasibility of the RESToRE program will be determined by measuring the number of participants who enroll.

    10 weeks

  • Number of participants who completed

    Feasibility of the RESToRE program will be determined by measuring the number of participants who complete (participated through the end of the study).

    10 weeks

  • Number of participants who adhered to session attendance

    Feasibility of the RESToRE program will be determined by measuring the number of participants who achieve ≥80% exercise adherence and session attendance.

    10 weeks

Secondary Outcomes (8)

  • PROMIS-29 scale score

    baseline and post intervention at 8 weeks

  • Rand 36-Item Health Survey (SF-36) score

    Baseline and Post Intervention at 8 weeks

  • VO2 % predicted from Cardiopulmonary Exercise Testing (CPET)

    Baseline and post intervention at 8 weeks

  • Number of participants with orthostatic hypocapnia.

    baseline and post intervention at 8 weeks

  • EuroQol: Education Quotient-5D Visual Analogue Scale score

    baseline and post intervention at 8 weeks

  • +3 more secondary outcomes

Study Arms (2)

RESToRE

EXPERIMENTAL

Participants will receive RESToRE, an interdisciplinary, hybrid 8- week intervention.

Behavioral: Restoring Energy with Sub-symptom Threshold Aerobic Rehabilitation Exercise

Light Stretching Exercise

ACTIVE COMPARATOR

The control group will receive 8-week, attention-matched, stretching and breathing exercises, supervised by a rehabilitation clinician.

Behavioral: Light Stretching/Breathing Exercises

Interventions

8 week exercise program. 20 minutes of home aerobic exercise most days, phone- based motivational exercise coaching and supervised exercise with our team exercise physiologist.

Also known as: RESToRE
RESToRE

The control group will receive 8-week, attention-matched, stretching and breathing exercises, supervised by a rehabilitation clinician (via 20-minute weekly video visits). Exercises performed 5 days a week will not increase HR significantly. Participants will record and track their HR with Apple watch and app; like RESToRE, fidelity of treatment will be objectively measured using HR data.

Light Stretching Exercise

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • English speaking
  • Age of 21 years or older
  • Diagnosis of long COVID
  • Score \>0 on energy, daily activities, sleep, chest tightness, or breathlessness on COPD Assessment Test or self-reported brain fog
  • Able to use a smartphone.

You may not qualify if:

  • \>70years old due to risk of sarcopenia
  • Frailty defined as gait speed \<1 m/s on 4- Meter Gait Speed (4MGS) test due to falls risk
  • Diagnosis of chronic cardiac or pulmonary disease, including atrial fibrillation, ME/CFS, post-concussion syndrome, chronic Lyme disease, lupus, or sarcopenia comorbidities (due to PEM and/or fatigue)
  • Medical history of ICU stay for COVID-19 illness due to risk of post-ICU syndrome and increased rehabilitation needs
  • Inability to ambulate independently and safely without a walking aide
  • Diagnosis of dementia or neurodegenerative disease, multiple sclerosis, or rheumatoid arthritis with associated cognitive dysfunction or fatigue.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Columbia University Irving Medical Center

New York, New York, 10032, United States

Location

MeSH Terms

Conditions

Post-Acute COVID-19 Syndrome

Interventions

Restore polishing pasteBreathing Exercises

Condition Hierarchy (Ancestors)

COVID-19Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesPost-Infectious DisordersChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsExercise Movement TechniquesPhysical Therapy Modalities

Study Officials

  • Anna Norweg, PhD

    Columbia University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 14, 2023

First Posted

December 15, 2023

Study Start

October 1, 2023

Primary Completion

January 15, 2024

Study Completion

January 15, 2024

Last Updated

June 6, 2024

Record last verified: 2024-06

Locations